This study confirmed through in vitro experiments that GPS protects against Tm-induced ovarian dysfunction by inhibiting the PI3K/Akt pathway, while in vivo experiments demonstrated its efficacy in alleviating ERS-related ovarian damage. Here, AKT1 is linked to amelogenesis imperfecta type 1G.